{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:46:38Z","timestamp":1786981598095,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"l"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11102-024-01383-2","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T05:05:33Z","timestamp":1707714333000},"page":"197-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study"],"prefix":"10.1007","volume":"27","author":[{"given":"Mussa H.","family":"Almalki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moayad A.","family":"Alsuraikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Almazrouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M","family":"AlDahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshal","family":"Alaqeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeber","family":"Mahzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishah","family":"Ekhzaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"1383_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol 72:377\u2013382","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1383_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/cjn.2015.301","volume":"43","author":"K Al-Dahmani","year":"2016","unstructured":"Al-Dahmani K, Mohammad S, Imran F, Theriault C, Doucette S, Zwicker D, Yip CE, Clarke DB, Imran SA (2016) Sellar masses: an epidemiological study. Can J Neurol Sci 43(2):291\u2013297. https:\/\/doi.org\/10.1017\/cjn.2015.301Epub 2015 Nov 2. PMID: 26522017","journal-title":"Can J Neurol Sci"},{"key":"1383_CR3","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33:101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1383_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"key":"1383_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11102-011-0318-z","volume":"15","author":"A Colao","year":"2011","unstructured":"Colao A (2011) Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Pituitary 15:50\u201358. https:\/\/doi.org\/10.1007\/s11102-011-0318-z","journal-title":"Pituitary"},{"key":"1383_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40265-019-01128-7","volume":"79","author":"JM Hinojosa-Amaya","year":"2019","unstructured":"Hinojosa-Amaya JM, Cuevas-Ramos D, Fleseriu M (2019) Medical management of Cushing\u2019s syndrome: current and emerging treatments. Drugs 79:935\u2013956. https:\/\/doi.org\/10.1007\/s40265-019-01128-7","journal-title":"Drugs"},{"key":"1383_CR7","doi-asserted-by":"publisher","first-page":"117955142093292","DOI":"10.1177\/1179551420932921","volume":"13","author":"MH Al Malki","year":"2020","unstructured":"Al Malki MH, Ahmad MM, Brema I, Al Dahmani KM, Pervez N, Al-Dandan S, Al Obaid A, Beshyah SA (2020) Contemporary Management of clinically non-functioning pituitary adenomas: a clinical review. Clin Med Insights Endocrinol Diabetes 13:1179551420932921. https:\/\/doi.org\/10.1177\/1179551420932921PMID: 32636692; PMCID: PMC7318824","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"1383_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fneur.2018.00330","volume":"9","author":"H Molde","year":"2018","unstructured":"Molde H, Moussavi Y, Kopperud ST, Erga AH, Hansen AL, Pallesen S (2018) Impulse-control disorders in Parkinson\u2019s disease: a meta-analysis and review of case-control studies. Front Neurol 9:330","journal-title":"Front Neurol"},{"key":"1383_CR9","doi-asserted-by":"crossref","unstructured":"Colao A, di Sarno A, Pivonello R, di Somma C, Lombardi G (2002) Dopamine receptor agonists for treating prolactinomas. Expert Opin Investig Drugs. 11(6):787\u2013800. doi: 10.1517\/13543784.11.6.787. PMID: 12036422","DOI":"10.1517\/13543784.11.6.787"},{"key":"#cr-split#-1383_CR10.1","doi-asserted-by":"crossref","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev","DOI":"10.1210\/er.2005-9998"},{"key":"#cr-split#-1383_CR10.2","doi-asserted-by":"crossref","unstructured":"27(5):485-534. doi: 10.1210\/er.2005-9998. Epub 2006 May 26. PMID: 16705142","DOI":"10.1210\/er.2005-9998"},{"key":"1383_CR11","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1530\/EJE-18-0667","volume":"179","author":"M Barake","year":"2018","unstructured":"Barake M, Klibanski A, Tritos NA (2018) Management of endocrine disease: impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry? Eur J Endocrinol 179:R287\u2013R296. https:\/\/doi.org\/10.1530\/EJE-18-0667","journal-title":"Eur J Endocrinol"},{"key":"#cr-split#-1383_CR12.1","doi-asserted-by":"crossref","unstructured":"Valassi E, Klibanski A, Biller BM (2010) Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab.","DOI":"10.1210\/jc.2009-2095"},{"key":"#cr-split#-1383_CR12.2","doi-asserted-by":"crossref","unstructured":"95(3):1025-33. doi: 10.1210\/jc.2009-2095. Epub 2010 Feb 3. PMID: 20130078","DOI":"10.1210\/jc.2009-2095"},{"key":"1383_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4321\/S1135-76062012000200003","volume":"18","author":"The biopsychological bases","year":"2012","unstructured":"The biopsychological bases (2012) Of criminal responsibility in impulsive behaviour. Ramos V. Cuad Med Forense 18:63\u201370","journal-title":"Cuad Med Forense"},{"key":"1383_CR14","volume-title":"Diagnostic and statistical Manual of Mental disorders-text revision","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical Manual of Mental disorders-text revision. DSM-IV TR), Washington, DC: American Psychiatric Association;"},{"key":"1383_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-18-0682","volume":"180","author":"AG Ioachimescu","year":"2019","unstructured":"Ioachimescu AG, Fleseriu M, Hoffman AR, Vaughan Iii TB, Katznelson L (2019) Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol 180:31\u201340. https:\/\/doi.org\/10.1530\/EJE-18-0682","journal-title":"Eur J Endocrinol"},{"key":"1383_CR16","first-page":"71","volume":"43","author":"PN Dannon","year":"2006","unstructured":"Dannon PN, Mester R (2006) Impulse control disorders: doesthe DSM-IV classification really explain everything about this typeof disorder? Isr. J Psychiatry Relat Sci 43:71\u201373","journal-title":"J Psychiatry Relat Sci"},{"key":"1383_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub D, Claassen DO (2017) Impulse control and related dis-orders in Parkinson\u2019s disease. Int Rev Neurobiol 133:679\u2013717","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"1383_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WNF.0b013e31829fc165","volume":"36","author":"SK Thondam","year":"2013","unstructured":"Thondam SK, Alusi S, O\u2019Driscoll K, Gilkes CE, Cuthbertson DJ, Daousi C (2013) Impulse control disorder in a patient on long-term treatment with bromocriptine for a macroprolactinoma. Clin Neuropharmacol 36(5):170\u2013172","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"1383_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.psym.2012.10.002","volume":"54","author":"S Almanzar","year":"2013","unstructured":"Almanzar S, Zapata-Vega MI, Raya JA (2013) Dopamine agonist-induced impulse control disorders in a patient with prolactinoma. Psychosomatics 54(4):387\u2013391","journal-title":"Psychosomatics"},{"issue":"7","key":"1383_CR20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1210\/jc.2018-02202","volume":"104","author":"SC Dogansen","year":"2019","unstructured":"Dogansen SC, Cikrikcili U, Oruk G, Kutbay NO, Tanrikulu S, Hekimsoy Z et al (2019) Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study. J Clin Endocrinol Metab 104(7):2527\u20132534","journal-title":"J Clin Endocrinol Metab"},{"key":"1383_CR21","doi-asserted-by":"crossref","unstructured":"De Sousa SMC, Baranoff J, Rushworth RL, Butler J, Sorbello J, Vorster J et al (2020) Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors. J Clin Endocrinol Metab","DOI":"10.1210\/clinem\/dgz076"},{"issue":"2","key":"1383_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12020-016-1088-1","volume":"55","author":"SM De Sousa","year":"2017","unstructured":"De Sousa SM, Chapman IM, Falhammar H, Torpy DJ (2017) Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endo-crine 55(2):618\u2013624","journal-title":"Endo-crine"},{"issue":"6","key":"1383_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"Bancos I, Nannenga MR, Bostwick JM, Silber MH, Erickson D, Nippoldt TB (2014) Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study. Clin Endocrinol (Oxf) 80(6):863\u2013868","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1383_CR24","doi-asserted-by":"crossref","unstructured":"Shlomo Melmed FF, Casanueva AR, Hoffman DL, Kleinberg VM, Montori JA, Schlechte JAH, Wass (February 2011) Diagnosis and treatment of Hyperprolactinemia: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism 96(2):273\u2013288","DOI":"10.1210\/jc.2010-1692"},{"issue":"8","key":"1383_CR25","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s40618-020-01478-0","volume":"44","author":"G Beccuti","year":"2021","unstructured":"Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, Montanaro E, Lopiano L, Ghigo E, Zibetti M, Grottoli S (2021) Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study. J Endocrinol Invest 44(8):1699\u20131706 Epub 2020 Dec 12. PMID: 33314003; PMCID: PMC8285332","journal-title":"J Endocrinol Invest"},{"key":"1383_CR26","doi-asserted-by":"publisher","unstructured":"Hamblin R, Karavitaki N. Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: a systematic review. Arch Med Res. 2023;54(8):102910. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102910. Epub 2023 Nov 19. PMID: 37985276.","DOI":"10.1016\/j.arcmed.2023.102910"},{"issue":"3","key":"1383_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12020-018-1744-8","volume":"62","author":"E Celik","year":"2018","unstructured":"Celik E, Ozkaya HM, Poyraz BC, Saglam T, Kadioglu P (2018) Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up. Endocrine 62(3):692\u2013700. https:\/\/doi.org\/10.1007\/s12020-018-1744-8","journal-title":"Endocrine"},{"issue":"1","key":"1383_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","volume":"41","author":"M Grall-Bronnec","year":"2018","unstructured":"Grall-Bronnec M, Victorri-Vigneau C, Donnio Y, Leboucher J, Rousselet M, Thiabaud E, Zreika N, Derkinderen P, Challet-Bouju G (2018) Dopamine agonists and Impulse Control disorders: a Complex Association. Drug Saf 41(1):19\u201375. https:\/\/doi.org\/10.1007\/s40264-017-0590-6PMID: 28861870; PMCID: PMC5762774","journal-title":"Drug Saf"},{"key":"1383_CR29","doi-asserted-by":"publisher","first-page":"579606","DOI":"10.3389\/fendo.2020.579606","volume":"11","author":"JM Hinojosa-Amaya","year":"2020","unstructured":"Hinojosa-Amaya JM, Johnson N, Gonz\u00e1lez-Torres C, Varlamov EV, Yedinak CG, McCartney S, Fleseriu M (2020) Depression and Impulsivity Self-Assessment Tools to identify dopamine Agonist Side effects in patients with Pituitary Adenomas. Front Endocrinol (Lausanne) 11:579606. https:\/\/doi.org\/10.3389\/fendo.2020.579606PMID: 33193096; PMCID: PMC7652723","journal-title":"Front Endocrinol (Lausanne)"}],"updated-by":[{"DOI":"10.1007\/s11102-024-01390-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000}}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01383-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01383-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T04:33:31Z","timestamp":1712896411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01383-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01383-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"31 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11102-024-01390-3","URL":"https:\/\/doi.org\/10.1007\/s11102-024-01390-3","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by a research ethics committee of the King Fahd Center for Medical Research in Riyadh.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work was supported by a small grant from the research center, King Fahd Medical City, Second Cluster Riyadh, Saudi Arabia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Fundung"}},{"value":"The authors confirm that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}